Events
Conferences, congresses and webinars where Philogen presents its science.
Philogen to attend the Antibody Engineering & Therapeutics on December 4-8, 2022 in San Diego
Philogen announces its attendance at the Antibody Engineering & Therapeutics 2022. Prof. Dario Neri, CEO and CSO of Philogen, is giving a lecture entitled…
Philogen’s management team held a webinar on 29 September 2022 at 16:00 CEST
Philogen held a virtual briefing on 29 September 2022 at 10:00 ET / 15:00 BST / 16:00 CEST following the Board of Directors’ approval of the Half-Yearly…
Philogen to attend the Peptide Therapeutic Forum 2022 on August 25-26, 2022
Philogen announces its attendance at the Peptide Therapeutic Forum 2022. Samuele Cazzamalli, Head of Small Molecule Therapeutics at Philogen, is giving a…
Philogen to attend the International Mass Spectrometry Congress 2022 in Maastricht (August 27th-September 2nd, 2022)
Dr. Ettore Gilardoni, Head of Bio-MS at Philogen, will present a poster entitled: A mass spectrometry-based method for the determination of in vivo…
Philogen to attend the Society for Immunotherapy of Cancer’s 37th Annual Meeting 2022 in Boston (8-12 November 2022)
Philogen attends the SITC Annual Meeting in November 2022. Teresa Hemmerle, PhD, Senior Project Manager, to present an abstract entitled “Combinatorial…
Philogen to attend EANO Congress in Vienna, Austria (15-18 September 2022)
Philogen will attend EANO Meeting in Vienna in September 2022. More details on the lecture held by Philogen will follow shortly. Please visit the EANO Meeting…
Philogen to attend the 10th International Symposium on DNA-Encoded Chemical Libraries in Boston (3-4 November 2022)
Philogen attends the Symposium on DNA-Encoded Chemical Libraries in November 2022. Prof. Dario Neri, PhD, CEO and CSO of Philogen, to give a presentation…
Philogen to attend the 13th World ADC San Diego 2022, San Diego, USA (6-9 September 2022)
Philogen will attend the 13th World ADC in San Diego (USA) in September 2022. Samuele Cazzamalli, Head of Small Molecules Therapeutics at Philogen, will give a…
Philogen to attend the 3rd Annual Cytokine-Based Drug Development Summit, Boston (July 26-29, 2022)
Philogen will attend the 3rd Annual Cytokine-Based Drug Development Summit in Boston. Roberto De Luca, Head of Antibody Therapeutics, will give a virtual…
Philogen to attend Bio Europe in Leipzig (October 24-26, 2022)
Philogen participates at the BIO-Europe 2022 in Leipzig, the international partnering event in the life science and pharma industry, on October 24-26, 2022…
Philogen to attend Emerging Technologies and Methodologies in Small Molecule Drug Discovery & Synthesis Symposium in Toledo (27-29 September 2022)
Philogen attends the Small Molecule Drug Discovery & Synthesis Symposium organized by Janssen in September 2022. Prof. Dario Neri, PhD, CEO and CSO of Philogen…
Philogen to attend the Festival of Biologics in Basel (2-4 November 2022)
Philogen attends the Festival of Biologics in Basel in November 2022. Roberto De Luca, PhD, Head of Antibody Therapeutics at Philogen, to give a presentation…
Philogen to the 12th European Post-Chicago Melanoma/Skin Cancer Meeting, 30-1 July
Philogen will be Bronze Sponsor of the Post-Chicago Meeting in Münich (30-1 July). Philogen will chair a Satellite Symposium on Friday July 1, 11.30-12.00 am…
Philogen to attend European Society for Medical Oncology, Paris (9-13 September 2022)
Philogen attends ESMO in September 2022. Tobias Weiss, MD/PhD, Neuro-Oncologist at the Universitätsspital Zürich, to give a presentation entitled “The…
Philogen R&D Update – Webinar on June 23, 2022
Philogen held a virtual briefing on 23 June 2022 at 10:00 ET / 15:00 BST / 16:00 CEST following an R&D Update. Prof. Dr. Dario Neri, Chief Executive Officer…
Philogen FY 2021 Virtual Briefing
Philogen kindly invites you to attend a virtual briefing for analysts on 1 April 2022 to discuss the Company’s Full Year 2021 Financial Results. Prof. Dr. Dario…
Philogen to attend Seminar on “Drug Sciences” organized by the University of Basel, March 23, 2022.
Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “From encoded combinatorial libraries to clinical-stage targeted therapeutics”
Philogen to attend the workshop “Il Sistema Ricerca-Industria in Italia” at Accademia dei Lincei (Rome, Italy) on March 18, 2022.
Philogen announces its attendance at the workshop “Il Sistema Ricerca-Industria in Italia” at Accademia dei Lincei (Rome, Italy). Dario Neri, co-founder, CEO…
Philogen to attend 12th Annual World ADC 2022 on March 29-31
Philogen announces its attendance at the 12th Annual World ADC London 2022. Samuele Cazzamalli, Head of Small Molecule Therapeutics at Philogen, is giving a…
Philogen to Participate at the 2022 UBS Global Healthcare Conference on May 23-25, 2022
UBS Conference provides an opportunity for investors to get a perspective of Philogen progresses and to meet CEO Dario Neri through a formal and a fireside…
Philogen to attend “Chemical Biology and Drug Discovery Research Seminars” at Imperial College, London on May 10, 2022
Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “From encoded combinatorial libraries to clinical-stage targeted therapeutics”. See Chemical…
Philogen to attend the TIDES Europe 2022 in Vienna, Austria (16-18 November)
Philogen will attend the TIDES Europe in Vienna in November 2022. Samuele Cazzamalli, Head of Small Molecules Therapeutics at Philogen, will give a lecture…
Philogen to give a lecture at the Institute Cancer Center, Amsterdam on April 5, 2022
Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “Antibody-Cytokine Fusions: from the bench to the clinic”.
Philogen to attend the Immune Oncology Summit in London on May 24, 2022
Dario Neri, co-founder, CEO and CSO, is giving a plenary lecture on Immune Oncology. See Immuno-Oncology for more details.
Philogen to join the Department of Radiology at Cambridge University (UK) for a lecture on June 22, 2022
Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “From encoded combinatorial libraries to clinical-stage radiopharmaceuticals”
Philogen to attend TIDES 2022 on May 9-12, 2022
Philogen announces its attendance at the TIDES 2022 (Oligonucleotide and Peptide Therapeutics) on May 9-12, 2022. Samuele Cazzamalli, Head of Small Molecule…
Philogen to Attend the AACR Annual Meeting on April 8-13, 2022
Philogen announces its attendance at the AACR Annual Meeting on April 8-13, 2022. Aureliano Zana, 3rd year PhD student at Philogen, is presenting an ePoster…
Philogen to attend World Federation of Neuro-oncology Societies (WFNOS 2022) Virtual 2022 Annual Meeting on March 24-27, 2022
Philogen is presenting a ePoster entitled “A novel tumor-targeting cytokine-based therapy in combination with lomustine displays promising anti-tumor activity…
Philogen to attend Jefferies Healthcare Conference in London (November 15-17, 2022)
Jefferies Healthcare Conference in London provides an opportunity for investors to get a perspective of Philogen progresses and to meet CEO, CSO Dario Neri…
Philogen to participate at the Italian Mid Cap Conference organised by Mediobanca on January 19-20, 2022
The Italian Midcap Conference provides an opportunity for investors to get a perspective of Philogen progresses and to meet CEO Dario Neri and CFO Laura Baldi…